- Home
- ECVT vs AVDL Comparison
ECVT vs AVDL Comparison
Compare ECVT & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECVT
- AVDL
- Stock Information
- Founded
- ECVT 1935
- AVDL 2015
- Country
- ECVT United States
- AVDL Ireland
- Employees
- ECVT N/A
- AVDL N/A
- Industry
- ECVT Major Chemicals
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- ECVT Industrials
- AVDL Health Care
- Exchange
- ECVT Nasdaq
- AVDL Nasdaq
- Market Cap
- ECVT 850.5M
- AVDL 963.6M
- IPO Year
- ECVT 2017
- AVDL 1996
- Fundamental
- Price
- ECVT $7.52
- AVDL $10.31
- Analyst Decision
- ECVT Strong Buy
- AVDL Strong Buy
- Analyst Count
- ECVT 5
- AVDL 6
- Target Price
- ECVT $10.50
- AVDL $24.00
- AVG Volume (30 Days)
- ECVT 883.7K
- AVDL 1.3M
- Earning Date
- ECVT 10-31-2024
- AVDL 11-12-2024
- Dividend Yield
- ECVT N/A
- AVDL N/A
- EPS Growth
- ECVT N/A
- AVDL N/A
- EPS
- ECVT 0.46
- AVDL N/A
- Revenue
- ECVT $695,340,000.00
- AVDL $138,160,000.00
- Revenue This Year
- ECVT $5.64
- AVDL $523.86
- Revenue Next Year
- ECVT $4.79
- AVDL $70.46
- P/E Ratio
- ECVT $16.34
- AVDL N/A
- Revenue Growth
- ECVT N/A
- AVDL 1523.50
- 52 Week Low
- ECVT $6.02
- AVDL $9.41
- 52 Week High
- ECVT $11.35
- AVDL $19.09
- Technical
- Relative Strength Index (RSI)
- ECVT 45.40
- AVDL 41.51
- Support Level
- ECVT $7.23
- AVDL $10.35
- Resistance Level
- ECVT $7.81
- AVDL $11.15
- Average True Range (ATR)
- ECVT 0.28
- AVDL 0.59
- MACD
- ECVT -0.10
- AVDL 0.10
- Stochastic Oscillator
- ECVT 23.33
- AVDL 44.34
About ECVT Ecovyst Inc.
Ecovyst Inc is a integrated and global provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has two reporting segments: (1) Ecoservices and (2) Advanced Materials & Catalysts. Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications. Maximum revenue is generated from Ecoservices segment.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.